Application to BNCT to endocrine-mediated tumors
Journal Article
·
· Transactions of the American Nuclear Society
OSTI ID:75836
Boron neutron capture therapy (BNCT) has been experiencing a recent resurgence in interest as a cancer treatment modality. Most of the focus involves brain tumors, specifically grade III/IV gliomas and metastatic melanoma. However, BNCT can also be considered for other tumors. Recent experiments by Oregon Health Sciences University and Oregon State University (OSU) investigators have explored the efficacy of BNCT for treating tumors found in endocrine glands. These tumors offer a unique advantage for BNCT because the tumor cells can be targeted by boron-loaded hormones through specific cell membrane receptors.
- OSTI ID:
- 75836
- Report Number(s):
- CONF-940602-; ISSN 0003-018X; TRN: 95:003867-0006
- Journal Information:
- Transactions of the American Nuclear Society, Vol. 70; Conference: 35. annual meeting of the American Nuclear Society, New Orleans, LA (United States), 11-16 Jun 1994; Other Information: PBD: 1994
- Country of Publication:
- United States
- Language:
- English
Similar Records
A D-D/D-T fusion reaction based neutron generator system for liver tumor BNCT
L-DOPA Preloading Increases the Uptake of Borophenylalanine in C6 Glioma Rat Model: A New Strategy to Improve BNCT Efficacy
Boron-10 quantification and microdosimetric studies in a clinical trial of BNCT
Conference
·
Wed Apr 02 00:00:00 EST 2003
·
OSTI ID:75836
+1 more
L-DOPA Preloading Increases the Uptake of Borophenylalanine in C6 Glioma Rat Model: A New Strategy to Improve BNCT Efficacy
Journal Article
·
Wed Oct 01 00:00:00 EDT 2008
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:75836
+9 more
Boron-10 quantification and microdosimetric studies in a clinical trial of BNCT
Journal Article
·
Tue Dec 31 00:00:00 EST 1996
· Transactions of the American Nuclear Society
·
OSTI ID:75836